Literature DB >> 14565553

Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose.

M V Vertzoni1, H A Archontaki, P Galanopoulou.   

Abstract

A reversed-phase high-performance liquid chromatographic method with detection at 242 nm was developed, optimized and validated for the determination of acetaminophen (A) and its major metabolites glucuronide (AG) and sulfate (AS) conjugates in rabbit plasma and urine after a toxic dose. m-Aminophenol was used as internal standard (IS). A Hypersil BDS RP-C18 column (250 x 4.6 mm), 5 microm particle size, was equilibrated with a mobile phase composed of aqueous buffer solution of KH2PO4 0.05 M containing 1% CH3COOH (pH 6.5) and methanol (95:5, v/v). Its flow rate was 1.5 ml/min. Calibration curves of A, AG and AS were linear in the concentration ranges of 0.5-250, 1-200, 0.5-100 microg/ml in plasma and 1-200, 0.5-150, 0.5-100 microg/ml in urine matrix, respectively. Limits of detection and quantitation were calculated in all cases and extensive recovery studies were also performed. Intra-day relative standard deviation (R.S.D.) for A, AG and AS in plasma was less than 5, 4, 2% and in urine less than 4, 7, 4%, respectively, while the corresponding inter-day values were 7, 6, 4% and 5, 8, 6%, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565553     DOI: 10.1016/s0731-7085(03)00246-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability.

Authors:  P Mian; M J van Esdonk; K T Olkkola; B C M de Winter; A Liukas; I Spriet; D Tibboel; M Petrovic; B C P Koch; K Allegaert
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

2.  Pharmacokinetics of intravenous paracetamol in elderly patients.

Authors:  Antti Liukas; Kristiina Kuusniemi; Riku Aantaa; Petri Virolainen; Mikko Niemi; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

3.  On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant Food.

Authors:  Marina Statelova; Konstantinos Goumas; Nikoletta Fotaki; René Holm; Mira Symillides; Christos Reppas; Maria Vertzoni
Journal:  AAPS J       Date:  2019-12-02       Impact factor: 4.009

4.  Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen.

Authors:  Huma Mehboob; Imtiaz Mahmood Tahir; Tahira Iqbal; Sadaf Saleem; Sofia Perveen; Aboubakker Farooqi
Journal:  Dose Response       Date:  2017-09-11       Impact factor: 2.658

5.  Glucosamine-paracetamol spray-dried solid dispersions with maximized intrinsic dissolution rate, bioavailability and decreased levels of in vivo toxic metabolites.

Authors:  Ahmed Mahmoud Abdelhaleem Ali; Ahmed Khames; Majed Mansour Alrobaian; Mohammad Hamaidi; Mohammed As Abourehab
Journal:  Drug Des Devel Ther       Date:  2018-09-21       Impact factor: 4.162

6.  Investigation of Intestinal Absorption and Excretion of Paracetamol in Streptozotocin-Induced Hyperglycemia.

Authors:  Petra Mészáros; Sára Kovács; Győző Kulcsár; Melinda Páskuj; Attila Almási
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.